Keywords: GlaxoSmithKline, Biological E, Joint venture, Combination vaccine, India, Developoing countries, Polio, Infectious diseases

GlaxoSmithKline and Biological E set up JV to develop combination vaccine

Article | 29 January 2013

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) and Indian vaccines company Biological E have entered into an agreement to form a 50/50 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in